AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
I am writing to express my admiration and support for Susan F. Wood, Ph.D., who described how the Food and Drug Administration has delayed approval of over-the-counter status for the Plan B emergency contraception ("Science, Medicine, and Decision Making," Guest Editorial, Nov. 1, p. 6).
The FDA's decision was not based on any scientific questions of the safety or efficacy of Plan B, nor did the decision involve consultations with the professional staff.
In response, Dr. Wood resigned as Assistant Commissioner for Women's Health and Director of the Office of Women's Health at the FDA. She is to be commended for her integrity and courage.
It is inspiring that she was willing to take a stand in the name of both science and women's ...
Source: HighBeam Research, FDA decisions raise concerns.(LETTERS)(Letter to the Editor)